- Home
- CEVA vs ORGO Comparison
CEVA vs ORGO Comparison
Compare CEVA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEVA
- ORGO
- Stock Information
- Founded
- CEVA 1999
- ORGO 1985
- Country
- CEVA United States
- ORGO United States
- Employees
- CEVA N/A
- ORGO N/A
- Industry
- CEVA Semiconductors
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CEVA Technology
- ORGO Health Care
- Exchange
- CEVA Nasdaq
- ORGO Nasdaq
- Market Cap
- CEVA 521.3M
- ORGO 620.3M
- IPO Year
- CEVA 2000
- ORGO N/A
- Fundamental
- Price
- CEVA $22.73
- ORGO $5.00
- Analyst Decision
- CEVA Strong Buy
- ORGO Buy
- Analyst Count
- CEVA 5
- ORGO 2
- Target Price
- CEVA $35.60
- ORGO $7.50
- AVG Volume (30 Days)
- CEVA 297.5K
- ORGO 724.8K
- Earning Date
- CEVA 08-11-2025
- ORGO 08-07-2025
- Dividend Yield
- CEVA N/A
- ORGO N/A
- EPS Growth
- CEVA N/A
- ORGO N/A
- EPS
- CEVA N/A
- ORGO N/A
- Revenue
- CEVA $106,353,000.00
- ORGO $429,531,000.00
- Revenue This Year
- CEVA $4.35
- ORGO $2.57
- Revenue Next Year
- CEVA $15.50
- ORGO $9.80
- P/E Ratio
- CEVA N/A
- ORGO N/A
- Revenue Growth
- CEVA 7.71
- ORGO N/A
- 52 Week Low
- CEVA $18.31
- ORGO $2.46
- 52 Week High
- CEVA $38.94
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- CEVA 51.52
- ORGO 57.40
- Support Level
- CEVA $21.45
- ORGO $4.90
- Resistance Level
- CEVA $23.06
- ORGO $5.14
- Average True Range (ATR)
- CEVA 0.72
- ORGO 0.23
- MACD
- CEVA -0.07
- ORGO 0.01
- Stochastic Oscillator
- CEVA 54.83
- ORGO 75.16
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.